Categories: Business News

Actavis to buy Forest Labs for $25bn

Kolkata February 19, 2014:- The world’s second-largest generic drugmaker Actavis is buying Forest Laboratories for about $25bn (£15bn) in its biggest-ever acquisition. 

Shares of Forest surged by nearly 30%, while Actavis stock rose by 5% after the equity and cash deal was revealed.  Dublin-based Actavis has spent billions of dollars buying up rival drug companies over the past three years in order to expand its products.

Its latest deal is expected to bring more than $1bn in cost savings.

The new combined company is forecast to have annual revenues of more than $15bn in 2015.

Actavis chief executive officer Paul Bisaro will lead the combined firm, which he called a “financially and commercially compelling” transaction.

“With this strategic combination, we create an innovative new model in specialty pharmaceuticals leadership, with size and scale, a balanced offering of strong brands and generics, a focus on strategic, lower-risk drug development, and – most important – the ability to drive sustainable organic growth,” he said in a statement.

Forest makes branded drugs such as Alzheimer’s drug Namenda and blood-pressure pill Bystolic.

Billionaire activist investor Carl Icahn is the company’s second-largest shareholder.- BBC

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

2 days ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

2 days ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

3 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

3 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

4 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

4 days ago